May 27, 2026

FOXC1 Duplications Linked to Early-Onset Glaucoma

FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.

Conexiant

May 20, 2026

FDA Approves Expanded Liquid Biopsy Panel

Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.

Conexiant

May 19, 2026

DNA Quality Outweighs Bone Source

Background DNA burden was more strongly associated with sequencing profile completeness than bone source in unidentified human remains.

Conexiant

May 19, 2026

Side Effects: When More Is Less

A gene variant that raises GLP-1 levels somehow makes GLP-1 drugs work worse. Plus: why your nose might still recover two years out, and what urine might eventually tell us about schizophrenia.

Conexiant

May 15, 2026

Genes May Help Identify Severe Male Infertility

Three amino acid metabolism genes showed diagnostic signal in testicular tissue, though small sample sizes and computational methods limit clinical translation.

Conexiant

May 15, 2026

Urine Markers May Aid Psych Diagnosis

Genetically predicted urinary metabolite levels were associated with schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder, and anorexia nervosa in a Mendelian randomization analysis.

Conexiant

May 14, 2026

Sex Differences Seen in Immune Cells

Single-cell analysis identified sex-biased immune-cell composition, gene expression, and genetic regulation in unstimulated blood immune cells

Conexiant

May 13, 2026

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

Conexiant

May 11, 2026

Nodular Fasciitis May Mimic Sarcoma

Molecular testing may help avoid overtreatment when benign soft-tissue tumors present with atypical clinical or histologic features.

Conexiant

May 07, 2026

Vitamin D: The Answer May Be Genetic

A post hoc D2d analysis found vitamin D3 supplementation was linked to lower diabetes risk only among patients with ApaI AC or CC genotypes.

Conexiant